Aemetis just printed its strongest quarter in years, and the equity is treating it like a bankruptcy filing. Q2 2026 revenue rose 20% to $62.7 million (from $52.2 million in Q2 2025), gross profit flipped to $13.5 million from a $3.4 million loss, and operating income turned positive at $5.8 million versus a $10.7 million operating loss a year ago. Adjusted EBITDA, a non-GAAP measure that adds back interest, depreciation, amortization, and stock-based compensation, was $9.7 million, a $15.5 million swing from negative $5.8 million in the prior-year quarter. The story, however, is not the headline print. The story is that management filed its second-quarter 10-Q on August 6, 2026 with a fresh going-concern paragraph, explicitly stating that "substantial doubt exists about our ability to continue as a going concern over the next twelve months" while the company is simultaneously generating cash from operations. The market is pricing the equity at $1.80, near its 52-week low of $1.30 and far below its 52-week high of $3.80, on a market capitalization of roughly $130 million, against a debt load approaching $416 million.
The mechanism that makes this trade interesting is the convergence of three forces. The Inflation Reduction Act's Section 45Z production tax credit, a per-gallon federal credit for low-carbon fuels that took effect January 1, 2025, is now flowing through the income statement ($8.6 million in Q2 alone). The dairy renewable natural gas segment, or Dairy RNG, is scaling on a 38% volume ramp (146,900 MMBtu sold, a thermal unit of energy, versus 106,400 in Q2 2025) as new digesters come online. And the California Ethanol segment, the legacy cash engine, posted gross profit of $8.9 million in Q2 after a $3.8 million loss a year earlier, on a 12% volume increase and a 9% price increase ($2.19/gallon vs. $2.01). The trade is whether the equity can re-rate off the bottom before the senior lender, Third Eye Capital, demands payment on the $94.9 million Revolving Notes Series B and the $40.7 million Revolving Credit Facility, both of which are due on demand at interest rates of prime plus 13.75%, equating to 20.50% as of quarter-end.
The single load-bearing risk is liquidity, not operating performance. The balance sheet at June 30, 2026 shows $0.97 million of unrestricted cash, $2.5 million of restricted cash, $415.9 million of total debt, of which $354.2 million is classified as current, and a stockholders' deficit of $322.1 million. The next twelve months require either refinancing the Third Eye Capital facilities, monetizing the Section 45Z credits on a regular basis, completing the planned India subsidiary initial public offering, or continuing to issue equity through the at-the-market program, which generated $13.7 million in proceeds during the first half of 2026. The next data point that tests this thesis is the Q3 2026 earnings release expected in early November 2026, where the market looks for three things: progress on the Mechanical Vapor Recompression (MVR) project at the Keyes ethanol plant coming online, the commissioning of two additional dairy digesters as guided, and any update on the Keyes long-term refinancing or India IPO process.